NO20003112L - Aryltiazolidinonderivater - Google Patents
AryltiazolidinonderivaterInfo
- Publication number
- NO20003112L NO20003112L NO20003112A NO20003112A NO20003112L NO 20003112 L NO20003112 L NO 20003112L NO 20003112 A NO20003112 A NO 20003112A NO 20003112 A NO20003112 A NO 20003112A NO 20003112 L NO20003112 L NO 20003112L
- Authority
- NO
- Norway
- Prior art keywords
- aryltiazolidinonderivater
- pparα
- thiazolidinediones
- hypertriglyceridemia
- ppar
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/44—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6827197P | 1997-12-19 | 1997-12-19 | |
| GBGB9816279.5A GB9816279D0 (en) | 1998-07-27 | 1998-07-27 | Arylthiazolidinedione derivatives |
| US10523898P | 1998-10-22 | 1998-10-22 | |
| PCT/US1998/027139 WO1999032465A1 (en) | 1997-12-19 | 1998-12-18 | Arylthiazolidinedione derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20003112D0 NO20003112D0 (no) | 2000-06-16 |
| NO20003112L true NO20003112L (no) | 2000-08-18 |
Family
ID=27269416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20003112A NO20003112L (no) | 1997-12-19 | 2000-06-16 | Aryltiazolidinonderivater |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1040102B1 (es) |
| JP (1) | JP3373198B2 (es) |
| KR (1) | KR20010033355A (es) |
| CN (1) | CN1282325A (es) |
| AT (1) | ATE352545T1 (es) |
| AU (1) | AU740733B2 (es) |
| BG (1) | BG104602A (es) |
| BR (1) | BR9813801A (es) |
| CA (1) | CA2315397C (es) |
| DE (1) | DE69836980T2 (es) |
| EA (1) | EA200000687A1 (es) |
| ES (1) | ES2281146T3 (es) |
| HU (1) | HUP0101366A2 (es) |
| ID (1) | ID24878A (es) |
| IL (1) | IL136138A0 (es) |
| IS (1) | IS5506A (es) |
| NO (1) | NO20003112L (es) |
| PL (1) | PL340958A1 (es) |
| SK (1) | SK9212000A3 (es) |
| TR (1) | TR200001753T2 (es) |
| WO (1) | WO1999032465A1 (es) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9824614D0 (en) | 1998-11-11 | 1999-01-06 | Glaxo Group Ltd | Chemical compounds |
| EP1053989B1 (en) * | 1999-05-20 | 2007-07-25 | Ciba SC Holding AG | Hydroxydiphenyl ether compounds |
| AU5876900A (en) * | 1999-06-18 | 2001-01-09 | Merck & Co., Inc. | Process for making arylthiazolidinedione derivatives |
| US6399640B1 (en) * | 1999-06-18 | 2002-06-04 | Merck & Co., Inc. | Arylthiazolidinedione and aryloxazolidinedione derivatives |
| US7041691B1 (en) | 1999-06-30 | 2006-05-09 | Amgen Inc. | Compounds for the modulation of PPARγ activity |
| US6417212B1 (en) | 1999-08-27 | 2002-07-09 | Eli Lilly & Company | Modulators of peroxisome proliferator activated receptors |
| AU1303301A (en) * | 1999-11-10 | 2001-06-06 | Takeda Chemical Industries Ltd. | Body weight gain inhibitors |
| US20030171399A1 (en) | 2000-06-28 | 2003-09-11 | Tularik Inc. | Quinolinyl and benzothiazolyl modulators |
| AU2001298065A1 (en) * | 2001-01-12 | 2003-09-02 | Abbott Laboratories | Process for the preparation of matrix metalloproteinase inhibitors |
| WO2002087580A1 (en) * | 2001-04-25 | 2002-11-07 | Takeda Chemical Industries, Ltd. | Abc expression promoters |
| US7125865B2 (en) * | 2002-07-25 | 2006-10-24 | Merck & Co., Inc. | Therapeutic compounds for treating dyslipidemic conditions |
| KR100736955B1 (ko) * | 2002-08-30 | 2007-07-09 | 에프. 호프만-라 로슈 아게 | Ｐｐａｒ알파 및 ｐｐａｒ감마 작용제로서의 신규한 2-아릴티아졸 화합물 |
| PT1567493E (pt) * | 2002-11-26 | 2009-04-09 | Pfizer Prod Inc | Activadores de ppar |
| CN1319956C (zh) * | 2003-09-12 | 2007-06-06 | 深圳市海粤门生物科技开发有限公司 | 一种噻唑烷二酮的衍生物及其药用制剂的制备方法和应用 |
| WO2005042478A2 (en) * | 2003-09-19 | 2005-05-12 | Janssen Pharmaceutica, N.V. | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| DE602004028500D1 (de) | 2003-09-19 | 2010-09-16 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyessigsäuren und analoga |
| DE602005001265T2 (de) * | 2004-01-20 | 2008-01-31 | Merck & Co., Inc. | Antidiabetische oxazolidindione und thiazolidindione |
| WO2006138328A1 (en) * | 2005-06-14 | 2006-12-28 | Merck & Co., Inc. | Process for the production of antidiabetic oxazolidinediones |
| CA2612765A1 (en) | 2005-07-06 | 2007-01-18 | Merck And Co., Inc. | Antidiabetic oxazolidinediones and thiazolidinediones |
| JP2009502783A (ja) * | 2005-07-20 | 2009-01-29 | メルク エンド カムパニー インコーポレーテッド | 抗糖尿病性オキサゾリジンジオン及びチアゾリジンジオン |
| MX2009013332A (es) | 2007-06-08 | 2010-01-25 | Mannkind Corp | Inhibidores de ire-1 alfa. |
| CN104987314A (zh) * | 2015-07-14 | 2015-10-21 | 佛山市赛维斯医药科技有限公司 | 含苯并异恶唑和末端硝基苄基类结构的化合物及其用途 |
| CN105001174A (zh) * | 2015-07-14 | 2015-10-28 | 佛山市赛维斯医药科技有限公司 | 含苯并异恶唑和末端腈基苄基类结构的化合物及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3053490B2 (ja) * | 1991-02-25 | 2000-06-19 | 杏林製薬株式会社 | チアゾリジン−２，４−ジオン誘導体とその塩及び製造法 |
| JP3906935B2 (ja) * | 1995-12-18 | 2007-04-18 | 杏林製薬株式会社 | Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 |
| AU721452B2 (en) * | 1996-02-02 | 2000-07-06 | Merck & Co., Inc. | Antidiabetic agents |
| JP2002515865A (ja) * | 1996-02-02 | 2002-05-28 | メルク エンド カンパニー インコーポレーテッド | 抗糖尿病薬 |
| WO1997028137A1 (en) * | 1996-02-02 | 1997-08-07 | Merck & Co., Inc. | Heterocyclic derivatives as antidiabetic and antiobesity agents |
| US5801173A (en) * | 1996-05-06 | 1998-09-01 | Dr. Reddy's Research Foundation | Heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them |
-
1998
- 1998-12-18 ID IDW20001163A patent/ID24878A/id unknown
- 1998-12-18 AT AT98963283T patent/ATE352545T1/de not_active IP Right Cessation
- 1998-12-18 CN CN98812229A patent/CN1282325A/zh active Pending
- 1998-12-18 EA EA200000687A patent/EA200000687A1/ru unknown
- 1998-12-18 IL IL13613898A patent/IL136138A0/xx unknown
- 1998-12-18 WO PCT/US1998/027139 patent/WO1999032465A1/en not_active Ceased
- 1998-12-18 EP EP98963283A patent/EP1040102B1/en not_active Expired - Lifetime
- 1998-12-18 JP JP2000525402A patent/JP3373198B2/ja not_active Expired - Fee Related
- 1998-12-18 HU HU0101366A patent/HUP0101366A2/hu unknown
- 1998-12-18 KR KR1020007006820A patent/KR20010033355A/ko not_active Withdrawn
- 1998-12-18 TR TR2000/01753T patent/TR200001753T2/xx unknown
- 1998-12-18 AU AU18334/99A patent/AU740733B2/en not_active Ceased
- 1998-12-18 ES ES98963283T patent/ES2281146T3/es not_active Expired - Lifetime
- 1998-12-18 PL PL98340958A patent/PL340958A1/xx not_active Application Discontinuation
- 1998-12-18 DE DE69836980T patent/DE69836980T2/de not_active Expired - Fee Related
- 1998-12-18 CA CA002315397A patent/CA2315397C/en not_active Expired - Fee Related
- 1998-12-18 SK SK921-2000A patent/SK9212000A3/sk unknown
- 1998-12-18 BR BR9813801-4A patent/BR9813801A/pt not_active Application Discontinuation
-
2000
- 2000-05-23 IS IS5506A patent/IS5506A/is unknown
- 2000-06-16 NO NO20003112A patent/NO20003112L/no not_active Application Discontinuation
- 2000-07-13 BG BG104602A patent/BG104602A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69836980T2 (de) | 2007-11-15 |
| EP1040102A1 (en) | 2000-10-04 |
| JP3373198B2 (ja) | 2003-02-04 |
| BG104602A (bg) | 2001-01-31 |
| HUP0101366A2 (hu) | 2001-09-28 |
| ATE352545T1 (de) | 2007-02-15 |
| EP1040102A4 (en) | 2002-11-27 |
| TR200001753T2 (tr) | 2000-11-21 |
| BR9813801A (pt) | 2000-10-03 |
| CA2315397A1 (en) | 1999-07-01 |
| CA2315397C (en) | 2007-08-07 |
| KR20010033355A (ko) | 2001-04-25 |
| WO1999032465A1 (en) | 1999-07-01 |
| JP2001526278A (ja) | 2001-12-18 |
| ID24878A (id) | 2000-08-31 |
| ES2281146T3 (es) | 2007-09-16 |
| AU1833499A (en) | 1999-07-12 |
| EA200000687A1 (ru) | 2000-12-25 |
| CN1282325A (zh) | 2001-01-31 |
| SK9212000A3 (en) | 2001-02-12 |
| NO20003112D0 (no) | 2000-06-16 |
| IS5506A (is) | 2000-05-23 |
| IL136138A0 (en) | 2001-05-20 |
| AU740733B2 (en) | 2001-11-15 |
| DE69836980D1 (de) | 2007-03-15 |
| EP1040102B1 (en) | 2007-01-24 |
| PL340958A1 (en) | 2001-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20003112L (no) | Aryltiazolidinonderivater | |
| WO2002064094A3 (en) | 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders | |
| ATE333448T1 (de) | Arylthiazolidinedione und aryloxa zolidinedion- derivate | |
| WO2002026729A3 (en) | Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders | |
| AU7705601A (en) | N-substituted indoles useful in the treatment of diabetes | |
| DE60023492D1 (de) | Glucagon antagonisten/inverse agonisten | |
| DK0546076T3 (da) | Anvendelse af anti-ICAM antistoffer til fremstilling af et lægemiddel til behandling af endotoksiskshock | |
| ATE242179T1 (de) | Verfahren und vorrichtung zum homogenen erwärmen von gläsern und/oder glaskeramiken mit hilfe von infrarot-strahlung | |
| DK0584292T3 (da) | Svingdør | |
| IL121203A0 (en) | Hypoglycemic and hypolipidemic compounds | |
| ECSP993022A (es) | Derivados de ariltiazolidindiona | |
| FI963785A0 (fi) | Hypokolesteroleemisia, antiateroskleroottisia ja hypotriglyserideemisiä merkaptoasetyyliamidijohdannaisia | |
| DK0458892T3 (da) | Anvendelse af chlormethiazol ved fremstillingen af et medikament til forebyggelsen og/eller behandlingen af neurodegeneration | |
| AR018898A1 (es) | Derivados de 5-aril-2,4-tiazolidindiona, una composicion farmaceutica que los comprende y el uso de los mismos para la fabricacion de un medicamento | |
| DK0463063T3 (da) | Hængselforbundet lamineret genstand | |
| FI963783A0 (fi) | Hypokolesteroleemisiä, antiateroskleroottisia ja hypotriglyserideemisiä aminoasetyylimerkaptojohdannaisia | |
| NO963988D0 (no) | Hypokolesterolemiske-, antiatherosklerotiske-, og hypotriglyceridemiske mercaptoacetylamidderivater | |
| DK1032490T3 (da) | Fremgangsmåde ved termo-mekanisk behandling af naturtræ, som er beskadiget eller vandfyldt og det således tilvejebragte produkt | |
| NO905292D0 (no) | Fremgangsmaate for behandling av slam som oppstaar ved elektroplettering av metaller. | |
| IT1225849B (it) | Cerniera a profilo costante |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |